7230Cx Marquis VR
Implantable Cardioverter Defibrillator (ICD)
7230Cx Marquis VR
Information

Device Survival Probability


7230_SURV
    1 yr 2 yr 3 yr 4 yr 5 yr 6 yr 7 yr 8 yr 9 yr at 114 mo
% Excluding Normal Battery Depletion 99.9 99.9 99.9 99.8 99.7 99.6 99.5 99.4 99.4 99.4
% Including Normal Battery Depletion 99.7 99.4 99.1 98.7 98.1 94.6 86.8 74.9 41.5 5.9
#   17350 13576 11353 10184 9107 7940 6573 5067 1996 173
  • Including Normal Battery Depletion – This curve includes devices that have reached at least 80% of expected longevity. This curve is most representative of clinical performance and how long the device will last.
  • Excluding Normal Battery Depletion – This is the malfunction free survival curve.

Performance Notes For This Model

    • There are no performance notes for this model.
Information

Product Characteristics

Generator Type ICD
NBD Code VVE-VVIR
Max. Delivered Energy 30J
More
Connector Style Cx Style
Serial Number Prefix PKD
Mass 75g
Volume 36cc
Waveform Biphasic
X-Ray ID PLW
Hide this content
Cx Style
Information

Estimated Longevity

Charging Frequency 100% Pacing 50% Pacing 15% Pacing 100% Sensing
Monthly 4.9 5.2 5.4 5.5
Quarterly 7.3 8.0 8.5 8.7
Semi-annual 8.5 9.3 10.0 10.4
Footnote

Longevity estimates based on the following device usage. Pacing Mode VVI; Ventricular Lower Pacing Rate 60ppm; Ventricular Pulse Width 0.4ms; Ventricular Pulse Amplitude 3V; Ventricle Impedance 510ohms; Ventricle Sensing Rate 70bpm; EGM prestorage OFF; Charging frequency assumes maximum energy charge and includes therapy shocks and capacitor formation. Hide this content

Information

EOL Indication

EOL device status is defined as three months following an ERI indication assuming the following post-ERI conditions: 100% VVI pacing at 60 ppm, 3 V, 0.4 ms; 500 Ohm pacing load; and six 30 J charges. EOL may be indicated before the end of three months if the device exceeds these conditions.

Information

Distribution Data

US Market Release2002-12-17
CE Approval Date2002-04-10
Registered USA Implants18568
Estimated Active USA Implants2181
Normal Battery Depletions2973
US Market Release2002-12-17
CE Approval Date2002-04-10
Estimated WW Distribution42309
Normal Battery Depletions3330
Information

Malfunctions (USA)

Therapy Function Not Compromised 31
Battery 1
Electrical Component 14
Possible Early Battery Depletion 14
Software/Firmware 1
Other 1
Therapy Function Compromised 26
Battery 17
Electrical Component 9
Information

Malfunctions (WW)

Therapy Function Not Compromised 76
Battery 6
Electrical Component 36
Electrical Interconnect 2
Possible Early Battery Depletion 26
Software/Firmware 5
Other 1
Therapy Function Compromised 52
Battery 34
Electrical Component 18
Information

Elective Replacement (ERI)

Battery voltage less than or equal to 2.62v or charge time greater than 16 seconds.

Information

Charge Time


7230_CHRG

Data as of January 31, 2014

www.medtronic.com/productperformance 301050